Morphologic and functional effects of gamma secretase inhibition on splenic marginal zone B cells

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  De Vera Mudry, Maria Cristina ^a   Regenass Lechner, Franziska ^a   Ozmen, Laurence ^a   Altmann, Bernd ^a   Festag, Matthias ^a   Singer, Thomas ^a   Müller, Lutz ^a   Jacobsen, Helmut ^a   Flohr, Alexander ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GAMMA SECRETASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; N (6,7 DIHYDRO 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL) 2,2 DIMETHYL N' (2,2,3,3,3 PENTAFLUOROPROPYL)PROPANEDIAMIDE; NOTCH RECEPTOR; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS VACCINE; VIRUS VACCINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLENIC MARGINAL ZONE B CELL; SPLENIC MARGINAL ZONE LYMPHOMA; VACCINATION; VESICULAR STOMATITIS; VESICULAR STOMATITIS VIRUS; VIRUS INACTIVATION;

EID: 84872153864     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/289412     Document Type: Article

References (22)

1. Pollack S. J., Lewis H., γ -Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease. Current Opinion in Investigational Drugs 2005 6 1 35 47 2-s2.0-12544258201
2. Kimberly W. T., Wolfe M. S., Identity and function of γ -secretase. Journal of Neuroscience Research 2003 74 3 353 360 2-s2.0-0242361783 10.1002/jnr.10736 (Pubitemid 37362811)
3. Gibb D. R., El Shikh M., Kang D. J., Rowe W. J., El Sayed R., Cichy J., Yagita H., Tew J. G., Dempsey P. J., Crawford H. C., Conrad D. H., ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. Journal of Experimental Medicine 2010 207 3 623 635 2-s2.0-77949528417 10.1084/jem.20091990
4. Baron M., An overview of the Notch signalling pathway. Seminars in Cell and Developmental Biology 2003 14 2 113 119 2-s2.0-0037376416 10.1016/S1084-9521(02)00179-9 (Pubitemid 36315877)
5. Rizzo P., Osipo C., Foreman K., Golde T., Osborne B., Miele L., Rational targeting of Notch signaling in cancer. Oncogene 2008 27 38 5124 5131 2-s2.0-50849111710 10.1038/onc.2008.226
6. Searfoss G. H., Jordan W. H., Calligaro D. O., Galbreath E. J., Schirtzinger L. M., Berridge B. R., Gao H., Higgins M. A., May P. C., Ryan T. P., Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ -secretase inhibitor. Journal of Biological Chemistry 2003 278 46 46107 46116 2-s2.0-0242412482 10.1074/jbc.M307757200 (Pubitemid 37432761)
7. Milano J., McKay J., Dagenais C., Foster-Brown L., Pognan F., Gadient R., Jacobs R. T., Zacco A., Greenberg B., Ciaccio P. J., Modulation of Notch processing by γ -secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicological Sciences 2004 82 1 341 358 2-s2.0-8444247084 10.1093/toxsci/kfh254 (Pubitemid 39485346)
8. Wong G. T., Manfra D., Poulet F. M., Zhang Q., Josien H., Bara T., Engstrom L., Pinzon-Ortiz M., Fine J. S., Lee H. J. J., Zhang L., Higgins G. A., Parker E. M., Chronic treatment with the γ -secretase inhibitor LY-411,575 inhibits γ -amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. Journal of Biological Chemistry 2004 279 13 12876 12882 2-s2.0-11144355129 10.1074/jbc.M311652200 (Pubitemid 38445862)
9. van Es J. H., van Gijn M. E., Riccio O., van Den Born M., Vooijs M., Begthel H., Cozijnsen M., Robine S., Winton D. J., Radtke F., Clevers H., Notch/ γ -secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005 435 7044 959 963 2-s2.0-20544460148 10.1038/nature03659 (Pubitemid 40896322)
10. Lopes-Carvalho T., Kearney J. F., Development and selection of marginal zone B cells. Immunological Reviews 2004 197 192 205 2-s2.0-0942268727 10.1111/j.0105-2896.2004.0112.x (Pubitemid 38142177)
11. Luistro L., He W., Smith M., Packman K., Vilenchik M., Carvajal D., Roberts J., Cai J., Berkofsky-Fessler W., Hilton H., Linn M., Flohr A., Jakob-Røtne R., Jacobsen H., Glenn K., Heimbrook D., Boylan J. F., Preclinical profile of a potent γ -secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. Cancer Research 2009 69 19 7672 7680 2-s2.0-70350236531 10.1158/0008-5472.CAN-09-1843
12. Scott D. W., Gershon R. K., Determination of total and mercaptoethanol-resistant antibody in the serum sample. Clinical & Experimental Immunology 1970 6 13 18
13. Charan S., Huegin A. W., Cerny A., Hengartner H., Zinkernagel R. M., Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice. Journal of Virology 1986 57 3 1139 1144 2-s2.0-0022633661 (Pubitemid 16143998)
14. Maillard I., Adler S. H., Pear W. S., Notch and the Immune System. Immunity 2003 19 6 781 791 2-s2.0-0346849694 10.1016/S1074-7613(03)00325-X (Pubitemid 37542299)
15. Tanigaki K., Han H., Yamamoto N., Tashiro K., Ikegawa M., Kuroda K., Suzuki A., Nakano T., Honjo T., Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nature Immunology 2002 3 5 443 450 2-s2.0-0036094254 10.1038/ni793 (Pubitemid 34520793)
16. Lutz C., Ledermann B., Kosco-Vilbois M. H., Ochsenbein A. F., Zinkernagel R. M., Kohler G., Brombacher F., IgD can largely substitute for loss of IgM function in B cells. Nature 1998 393 6687 797 801 2-s2.0-0032565864 10.1038/31716 (Pubitemid 28299492)
17. Gatto D., Ruedl C., Odermatt B., Bachmann M. F., Rapid response of marginal zone B cells to viral particles. Journal of Immunology 2004 173 7 4308 4316 2-s2.0-4644225155 (Pubitemid 39280658)
18. http://www.clinicaltrials.gov/ct2/results?term=RO4929097
19. Tolcher A. W., Messersmith W. A., Mikulski S. M., Papadopoulos K. P., Kwak E. L., Gibbon D. G., Patnaik A., Falchook G. S., Dasari A., Shapiro G. I., Boylan J. F., Xu Z.-X., Wang K., Koehler A., Song J., Middleton S. A., Deutsch J., DeMario M., Kurzrock R., Wheler J. J., Phase I study of RO4929097, a gamma secretase inhibitor of notch signaling, in patients with refractory metastatic or locally advanced solid tumors. Journal of Clinical Oncology 2012 30 19 2348 2353 10.1200/JCO.2011.36.8282
20. Schepmann D., Wünsch B., Frontiers in medicinal chemistry 2010: the highlights. ChemMedChem 2010 5 6 949 954 2-s2.0-77953086769 10.1002/cmdc. 201000193
21. http://newsroom.lilly.com/releasedetail.cfm?releaseid=499794
22. Blackman S. C., Klappenbach J. A., Railkar R. A., Tanis K., Podtelezhnikov A., Loboda A., Dai X., Hing J., Stone J., Harman A., Hardwick J., Iannone R., Bergstrom D., Identification of a time and dose-responsive transcriptional signature of Notch pathway inhibition in plucked human hair follicles following exposure to the gamma-secretase inhibitor MK-0752. Molecular Cancer Therapeutics 2009 8 supplement 12. abstract B41